Bertaut, A., Truntzer, C., Madkouri, R., Kaderbhai, C. G., Derangère, V., Vincent, J., . . . Ghiringhelli, F. (2016). Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. Oncotarget.
Citação norma ChicagoBertaut, Aurélie, et al. "Blood Baseline Neutrophil Count Predicts Bevacizumab Efficacy in Glioblastoma." Oncotarget 2016.
MLA CitationBertaut, Aurélie, et al. "Blood Baseline Neutrophil Count Predicts Bevacizumab Efficacy in Glioblastoma." Oncotarget 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.